← Back to patent-cliff list
Celecoxib/Famciclovir
Tier C — Watch / tradeCelecoxib/Famciclovir
Virios Therapeutics Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：COX-2, UL30, UL54
Indications (approved)：Fibromyalgia, Irritable bowel syndrome
Regional status
US
Phase II
2021-06-03
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Celecoxib/Famciclovir?
Approved indications include: Fibromyalgia, Irritable bowel syndrome.
When does the Celecoxib/Famciclovir patent expire?
No public expiry year is available for Celecoxib/Famciclovir yet; this page updates once verified.
How do I get a quote for Celecoxib/Famciclovir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21